Study design including amendments to standard (ICH/OECD/EPA guideline) designs based on expected pharmacological/class-based considerations or to follow up previous equivocal findingsSelection of suitable laboratories for study placement Study monitoring to ensure compliance with GLP and early availability of interim findings and allowing adaption of pre-clinical programme if findings so require Data review and interpretation, including a detailed understanding of procedures, and their inherent limitations, permitting expert insight into the validity, strength and accuracy of the conclusions Report writing or peer review Integration of data from 2 or more sources to give overall conclusion Assistance with REACH dataset summaries
Study design including amendments to standard (ICH/OECD/EPA guideline) designs based on expected pharmacological/class-based considerations or to follow up previous equivocal findingsSelection of suitable laboratories for study placement Study monitoring to ensure compliance with GLP and early availability of interim findings and allowing adaption of pre-clinical programme if findings so require Data review and interpretation, including a detailed understanding of procedures, and their inherent limitations, permitting expert insight into the validity, strength and accuracy of the conclusions Report writing or peer review Integration of data from 2 or more sources to give overall conclusion Assistance with REACH dataset summaries
Company Information
- Industry
- Pharmaceuticals
- Company Type
- Privately Held
- Founded
- unknown
- Employee Range
- 1-10
- Revenue Range
- Not available
Location
- Address
- Edinburgh
- City
- Region
- Postal Code
- EH4 2AU
- Country